Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.205 USD | -7.35% | -12.30% | -43.04% |
06-24 | Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study | MT |
06-24 | Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.04% | 76.18M | |
+38.65% | 39.1B | |
-7.49% | 38.76B | |
+27.86% | 31.24B | |
+13.50% | 25.9B | |
-13.50% | 25.8B | |
+45.45% | 14.06B | |
+39.51% | 13.12B | |
-6.76% | 11.32B | |
-12.16% | 10.68B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study